Marni Falk, MD
Executive Director, Mellowes Institute for Genomic Medicine and Precision Therapeutics
Locations
- Mellowes Institute
- HRC 5160
Contact Information
Publications
-
(Remes C, Mathew ND, Miranda V, Haroon S, O'Hara T, Anderson VE, Lavorato M, Keith K, Xiao R, Nakamaru-Ogiso E, Falk MJ.) J Inherit Metab Dis. 2026 Nov;49(6):e70257 PMID: 42844987 PMCID: PMC13646854 SCOPUS ID: 2-s2.0-105052770866 10/08/2026
-
Rare science, real impact: shaping the future of research on rare metabolic diseases.
(Suomalainen A, DeBerardinis RJ, Baruteau J, Puccio H, Otomo T, Falk MJ.) Nat Metab. 2026 Oct;8(10):2045-2047 PMID: 42778583 SCOPUS ID: 2-s2.0-105051558041 09/24/2026
-
NanoTS: a deep learning tool for accurate SNP calling in nanopore long-read transcriptome data.
(Liu Z, Wang F, Wang R, Wu DW, DeBruyne N, Keith K, McCormick EM, Park JJ, Sullenberger MT, Edmondson AC, Falk MJ, Lin L, Xing Y.) Nat Methods. 2026 Oct;23(10):1968-1972 PMID: 42773294 PMCID: PMC13645616 SCOPUS ID: 2-s2.0-105051439866 09/23/2026
-
Phase III trial of sodium dichloroacetate for pyruvate dehydrogenase complex deficiency in children.
(Stacpoole PW, Abdenur JE, Bedoyan JK, Botto L, Enns GM, Falk MJ, Ganetzky R, Garganta C, Glinton K, Gropman A, Hamm S, Henry E, Longo N, Neiberger R, Saneto RP, Scaglia F, Subramony SH, Vockley J, Wagner RE.) JCI Insight. 2026 Sep 22;11(18) PMID: 42770298 PMCID: PMC13596729 SCOPUS ID: 2-s2.0-105051134960 09/22/2026
-
Advances in diagnosis of mitochondrial dysfunction and primary mitochondrial disease.
(Kose M, McCormick E, Peterson JT, Muraresku C, Viaene A, Zolkipli-Cunningham Z, Falk MJ.) Dis Model Mech. 2026 Sep 01;19(9) PMID: 42817721 PMCID: PMC13670366 SCOPUS ID: 2-s2.0-105052182624 10/01/2026
-
(Keith K, Peng M, Remes C, Miranda V, Wachowski N, Kose M, Dharaskar S, Haroon S, Velasco AB, Sivaramakrishnan P, Iadarola D, Dugar S, Falk MJ.) bioRxiv. 2026 Jul 24 PMID: 42539297 PMCID: PMC13420416 08/01/2026
-
(Iadarola DM, Cabrera J, Nakamaru-Ogiso E, Falk MJ.) J Vis Exp. 2026 Jul 10(233) PMID: 42507606 07/27/2026
-
(Shen L, Lott MT, Mccormick EM, Muraresku CC, Keller K, Wallace DC, Zolkipli-Cunningham Z, Rahman S, Falk MJ, Gai X.) Genes (Basel). 2026 Jun 30;17(7) PMID: 42510797 PMCID: PMC13408853 SCOPUS ID: 2-s2.0-105045881811 07/28/2026
-
(Sultan LR, Morgan TA, McGinn DE, Darge K, Gendler L, Nguyen J, Brennan E, Brother JA, Xiao R, Falk MJ, Nadkarni V, Ischiropoulos H, Adams JA, Zolkipli Cunningham Z.) Ther Adv Rare Dis. 2026;7:26330040261486870 PMID: 42718981 PMCID: PMC13554588 09/10/2026
-
(Adams JA, Ko T, Sultan LR, Sarna T, McGinn D, Uryash A, Lopez JR, Nadkarni V, Xiao R, Falk MJ, Ischiropoulos H, Zolkipli-Cunningham Z.) Ther Adv Rare Dis. 2026;7:26330040261480132 PMID: 42707614 PMCID: PMC13547808 09/08/2026
-
(MacMullen LE, Stanley KD, Christodoulou J, Cohen BH, Demczko M, Goldstein AC, Haas R, Koenig MK, Poblete M, Rice A, Rossman I, Ruiz C, Russo SN, Thorburn DR, Uebergang E, Yang JH, Zolkipli-Cunningham Z, Falk MJ, Leigh Syndrome Roadmap Project Natural History Study Consortium.) Ther Adv Rare Dis. 2026;7:26330040261476231 PMID: 42662191 PMCID: PMC13519198 08/28/2026
-
Cancer prevalence in primary mitochondrial disease patients and their families.
(Dalwadi S, Engelhardt NM, Muraresku CC, Keith K, Valverde KD, Nathanson KL, Falk MJ.) Ther Adv Rare Dis. 2026;7:26330040261471914 PMID: 42539989 PMCID: PMC13424766 08/02/2026